Test Directory
Test Code | |||||||||||||
6CFTR | |||||||||||||
Test Name | |||||||||||||
Cystic Fibrosis Carrier Screening | |||||||||||||
CPT Codes | |||||||||||||
81220 | |||||||||||||
Clinical Utility | |||||||||||||
Genetic analysis to identify individuals at risk of having a child with Cystic Fibrosis. Recommended for all women who are pregnant or are considering pregnancy, per ACOG guidelines, and for individuals with a family history of Cystic Fibrosis. | |||||||||||||
Specimen and Container Info | |||||||||||||
NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico. |
|||||||||||||
Transport Instructions | |||||||||||||
|
|||||||||||||
Stability Requirements | |||||||||||||
|
|||||||||||||
Causes for Rejection | |||||||||||||
|
|||||||||||||
Methodology | |||||||||||||
Next Generation Sequencing and Copy Number Variation Analysis | |||||||||||||
Performing Location | |||||||||||||
Genomics - Snowdrift | |||||||||||||
Alternate Names | |||||||||||||
|
|||||||||||||
Description | |||||||||||||
This test is designed to detect carriers of cystic fibrosis. Cystic fibrosis (CF) is an autosomal recessive disorder of variable severity that affects the pulmonary system, digestive system, and other organ systems. Clinical features of CF include progressive lung disease, pancreatic insufficiency, male infertility, and elevated sweat chloride levels. Severely affected individuals may require lung transplantation and have shortened life expectancies, primarily due to respiratory failure. Other individuals have milder symptoms, including some males in whom the only finding is infertility due to congenital absence of the vas deferens (CAVD). Cystic fibrosis (MIM 219700) and CAVD (MIM 277180) are caused by pathogenic variants in the CFTR gene (NM_000492). Individuals with a heterozygous pathogenic variant in CFTR are carriers for cystic fibrosis/CAVD and are at risk of having a child with the disorder. If both reproductive partners are cystic fibrosis carriers, the risk for cystic fibrosis in their children is 25%. Cystic fibrosis has a high incidence in non-Hispanic white populations (approximately 1 in 2500 individuals), and a lower prevalence in other ethnic groups. Approximately 70% of CF carriers in non-Hispanic white populations carry the p.Phe508del (deltaF508) pathogenic variant. The American College of Obstetrics and Gynecology (ACOG) recommends offering cystic fibrosis carrier screening to all women who are pregnant or considering pregnancy. This test is intended for pre/post-conception carrier screening and is not intended for diagnostic testing. |
|||||||||||||
Testing Schedule | |||||||||||||
Monday-Friday | |||||||||||||
Genes | |||||||||||||
CFTR | |||||||||||||
MIM | |||||||||||||
219700, 277180 |
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2024 HNL Lab Medicine. All rights reserved.